$51M portfolio. 13 brands. Zero room for compliance failures.
IPG Health managed pharmaceutical marketing for Novartis (6 brands including Kesimpta) and Sanofi (7 brands). Each brand had different MLR requirements, regional variations, and approval workflows.
I embedded with both client teams and internal production staff. Mapped existing workflows, identified bottlenecks, and cataloged compliance failures. The pattern was clear: 30% of submissions were rejected not for content quality, but for process violations.
Teams were using spreadsheets to track approvals, email chains for reviews, and shared drives with inconsistent naming. No single source of truth. No audit trail. No way to demonstrate compliance during inspections.

Compliance Status by Client — Before AI Playbooks
30% of content was non-compliant or pending review, causing delays and rework across both portfolios.



